Maze Therapeutics, Inc.
NASDAQ:MAZEBiotechnology
Healthcare
$32.43 +0.74%
+$0.18 today
- Market cap
- $1.77B
- Beta
- 2.26
- P/E (TTM)
- -11.0
- EPS (TTM)
- -$2.27
52W Low $9.83High $53.65
Volume 1.00M
Average 0.84M
Balance Sheet
Inspect the capital base behind the business.
Assets
$397.13M
FY 2025 · Annual
+65.1% YoYLiabilities
$42.16M
FY 2025 · Annual
-3.4% YoYEquity
$354.97M
FY 2025 · Annual
+80.3% YoYBalance Sheet
USD
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $198.8M |
| Short-term Investments | $153.6M |
| Receivables | $20.0M |
| Other Current | $7.4M |
| Total Current Assets | $379.8M |
| PP&E (Net) | $24.0M |
| Long-term Investments | $10.6M |
| Other Non-current | $5.4M |
| Total Non-current Assets | $39.9M |
| Total Assets | $419.7M |
Analysis
Selected assets total $419.7M for Latest. The largest visible component is Cash & Equivalents at $198.8M, about 47.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 9, 2026 | |
| 10-Q | Quarterly report | Nov 9, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 4, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 30, 2026 | |
| 8-K | Current report | Oct 16, 2026 |
How much cash does MAZE have?
Maze Therapeutics, Inc. (MAZE) reported $189.25M in cash and equivalents in fiscal 2025.
How much debt does MAZE carry?
Maze Therapeutics, Inc. (MAZE) reported $23.31M of total debt, with net debt of -$165.94M.
Continue the stock analysis
Jump to another research area for this company.